FM
VTVT icon

Frazier Management’s vTv Therapeutics VTVT Stock Holding History

Frazier Management’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-26,550
Closed -$1.88M – 37
2020
Q3 		$1.88M Hold
26,550
– – 0.17% 27
2020
Q2 		$2.39M Hold
26,550
– – 0.21% 23
2020
Q1 		$2.03M Buy
+26,550
New +$2.55M 0.23% 23

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WAG
Winthrop Advisory Group Boston, Massachusetts $1.48B AUM 22.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return

Frazier Management's VTVT Position: Q4 2020 in Review

Frazier Management sold out of vTv Therapeutics (VTVT) in Q4 2020, closing a stake of 26,550 shares — an estimated $1.88M sold.

Frazier Management first reported a position in VTVT in Q1 2020 and held it in 3 quarters. The position peaked at $2.39M in Q2 2020. 44 funds tracked by Wall St. Rank hold VTVT as of Q4 2020.

  • Frazier Management reported no remaining vTv Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Frazier Management sold 26,550 vTv Therapeutics shares in Q4 2020, an estimated $1.88M.
  • Frazier Management first reported a position in vTv Therapeutics in Q1 2020 and held it in 3 quarters.
  • Frazier Management's vTv Therapeutics position peaked at $2.39M in Q2 2020.
  • 44 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2020.

Based on Frazier Management's 13F filing for Q4 2020, filed 11 Feb 2021.